Drug Shortage Report for SANDOZ LACOSAMIDE
Report ID | 73858 |
Drug Identification Number | 02474689 |
Brand name | SANDOZ LACOSAMIDE |
Common or Proper name | LACOSAMIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | LACOSAMIDE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-01-25 |
Estimated end date | 2019-04-26 |
Actual end date | 2019-04-29 |
Shortage status | Resolved |
Updated date | 2019-05-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-05-01 | French | Compare |
v9 | 2019-05-01 | English | Compare |
v8 | 2019-04-17 | French | Compare |
v7 | 2019-04-17 | English | Compare |
v6 | 2019-04-01 | French | Compare |
v5 | 2019-04-01 | English | Compare |
v4 | 2019-02-04 | French | Compare |
v3 | 2019-02-04 | English | Compare |
v2 | 2019-01-30 | French | Compare |
v1 | 2019-01-30 | English | Compare |
Showing 1 to 10 of 10